Get started
Author

Angela Albanese

Observed name: ALBANESE, ANGELA
ORCID: 0000-0001-5340-5392
Observed ORCID: 0000-0001-5340-5392
OpenAlex ID: A5000204684
The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review
2023 · Gianmarco Bellucci, Angela Albanese, et al. · Frontiers in Immunology · 22
PDF
Disease-Modifying Drugs and Breastfeeding in Multiple Sclerosis: A Narrative Literature Review
2022 · Fioravante Capone, Angela Albanese, et al. · Frontiers in Neurology · 21
PDF
COVID-19 severity among patients with multiple sclerosis treated with cladribine: A systematic review and meta-analysis
2022 · Angela Albanese, Maria Pia Sormani, et al. · Multiple Sclerosis and Related Disorders · 11
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study ( CladStop )
2024 · Irene Schiavetti, Alessio Signori, et al. · European Journal of Neurology · 9
PDF
Real-world experience with cladribine in the two years since treatment start: A systematic review and meta-analysis
2025 · Angela Albanese, Irene Schiavetti, et al. · Multiple Sclerosis and Related Disorders · 4
PDF
Long‐Term Disease Control Following Completion of Cladribine Treatment in Multiple Sclerosis: Extended Follow‐Up of the CladStop Cohort
2026 · Irene Schiavetti, Alessio Signori, et al. · European Journal of Neurology
PDF
Multiple Sclerosis in Patients Over 50: Immunosenescence, Comorbidities, and the Role of Cladribine Tablets
2026 · Roberta Lanzillo, Luca Battistini, et al. · Current Neuropharmacology
Works count: 8
Citation count: 67
H-index: 4
I10-index: 3
Year
Topic
Type